Enbrel 50 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F9S74
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,278
Award facts
- Contract value 100% obligated
- $32,277.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,277.87 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL syringes on December 29, 2025, with an ultimate completion date of December 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
Enbrel, a biologic immunosuppressant used primarily to treat rheumatoid arthritis and other autoimmune conditions, is a key pharmaceutical commodity supporting Department of Defense healthcare operations. This delivery order reflects the routine pharmaceutical supply chain management conducted through the DLA's medical supply operations, which leverage AmerisourceBergen's extensive network and inventory management capabilities to meet immediate healthcare needs for active-duty service members, military retirees, and veteran populations. The firm fixed-price structure and narrow completion window demonstrate the operational efficiency required for pharmaceutical supply chain execution within federal military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9S74?
SPE2DR26F9S74 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F9S74 worth?
The government has obligated $32,278 on SPE2DR26F9S74.
Is contract SPE2DR26F9S74 an order under another contract?
Yes. SPE2DR26F9S74 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9S74 competed?
The extent of competition for SPE2DR26F9S74 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award